Publications by authors named "Alejandro Piris-Gimenez"

Claim this Profile
W
Worldwide Innovative Network (WIN) Consortium in Personalized Cancer Medicine: Bringing next-generation precision oncology to patients.
Wafik S El-Deiry, Catherine Bresson, Fanny Wunder, Benedito A Carneiro, Don S Dizon

Oncotarget· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer Core Europe: Leveraging Institutional Synergies to Advance Oncology Research and Care Globally.
Javier Carmona, Elena Chavarria, Kate Donoghue, Christina von Gertten, Petra Oberrauch

Cancer Discov· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RNF43 mutations predict response to anti-BRAF/EGFR combinatory therapies in BRAF metastatic colorectal cancer.
Elena Elez, Javier Ros, Jose Fernández, Guillermo Villacampa, Ana Belén Moreno-Cárdenas, Alejandro Piris-Gimenez

Nat Med· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
ERANET JTC 2011: Submission and Activation of an International Academic Translational Project in Advanced Breast Cancer. Experience From the ET-FES Study.
Manuela Monti, Tom Degenhardt, Etienne Brain, Rachel Wuerstlein, Alessandra Argusti, Alejandro Piris-Gimenez

Front Med (Lausanne)· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: Caring for patients with cancer in the COVID-19 era.
Joris van de Haar, Louisa R Hoes, Charlotte E Coles, Kenneth Seamon, Stefan Fröhling

Nat Med· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Caring for patients with cancer in the COVID-19 era.
Joris van de Haar, Louisa R Hoes, Charlotte E Coles, Kenneth Seamon, Stefan Fröhling

Nat Med· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New clinical trial designs in the era of precision medicine.
Elena Garralda, Rodrigo Dienstmann, Alejandro Piris-Giménez, Irene Braña, Jordi Rodon

Mol Oncol· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interrogating open issues in cancer medicine with patient-derived xenografts.
Annette T Byrne, Denis G Alférez, Frédéric Amant, Daniela Annibali, Joaquín Arribas, Alejandro Piris-Gimenez

Nat Rev Cancer· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interrogating open issues in cancer precision medicine with patient-derived xenografts.
Annette T Byrne, Denis G Alférez, Frédéric Amant, Daniela Annibali, Joaquín Arribas, Alejandro Piris-Gimenez

Nat Rev Cancer· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vivo germination of Bacillus anthracis spores during murine cutaneous infection.
Jean-Philippe Corre, Alejandro Piris-Gimenez, Marie Moya-Nilges, Gregory Jouvion, Agnes Fouet

J Infect Dis· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Encapsulated Bacillus anthracis interacts closely with liver endothelium.
Alejandro Piris-Gimenez, Jean-Philippe Corre, Gregory Jouvion, Thomas Candela, Huot Khun

J Infect Dis· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Primary involvement of pharynx and peyer's patch in inhalational and intestinal anthrax.
Ian J Glomski, Alejandro Piris-Gimenez, Michel Huerre, Michèle Mock, Pierre L Goossens

PLoS Pathog· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vivo protective role of human group IIa phospholipase A2 against experimental anthrax.
Alejandro Piris-Gimenez, Miguel Paya, Gérard Lambeau, Michel Chignard, Michèle Mock

J Immunol· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High bactericidal efficiency of type iia phospholipase A2 against Bacillus anthracis and inhibition of its secretion by the lethal toxin.
Alejandro Piris Gimenez, Yong-Zheng Wu, Miguel Paya, Christophe Delclaux, Lhousseine Touqui

J Immunol· July 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis